Florent Le Prado

Collaborateur

Paris + 33.1.56.59.38.04

Contact

Partager

Florent Le Prado intervient dans tous les domaines du private equity (capital-risque, growth equity et buy-out), des fusions-acquisitions et du droit boursier.

Il accompagne principalement des entreprises de croissance (cotées ou non) et les investisseurs qui les financent, particulièrement dans les secteurs du logiciel, de la transition énergétique, des biotech/medtech et de la fintech, à tous les stades de leur développement, depuis leur création jusqu'à leur cession ou leur introduction en bourse et, au-delà, dans leur vie de sociétés cotées.

Les entreprises récemment représentées par Florent Le Prado comptent notamment Adikteev, Alizé Pharma, Cellectis, Contentsquare, CVE, Doctolib, Edgar Suites, Eurobio Scientific, Fintecture, Ivalua, Kyotherm, Lifen, Newheat, Ouicar, Paylead, PlayPlay, Pretto, SuperSonic Imagine, TxCell et Welcome to the Jungle ; et les investisseurs stratégiques ou financiers Alven Capital Partners, Bpifrance, ChapsVision, Crane Venture Partners, Creadev, Elaia Partners, Fluxys, Foundamental, IDIA Capital Investissement, New Alpha Asset Management, OCCTE, Open CNP, Portage Ventures, Serena Capital, Sofinnova, Temasek et Tikehau Capital.

Parmi les opérations représentatives de son expérience figurent les derniers tours de financement de Cellectis, Contentsquare, CVE, CVE Biogaz, Edgar Suites, InnovaFeed, Kyotherm, Ivalua, John Cockerill Hydrogen, Melvan, Moon Surgical, Mooncard, Newheat, OSS Ventures et Welcome to the Jungle ; les opérations de croissance externe de Doctolib, les acquisitions de Heap par Contentsquare, eSoftThings par Lacroix Group et Pipplet par ETS Global ; les cessions de Vialink à Signaturit et Heuritech à Luxurynsight ; les LBOs de Brico Privé par Florac et Orolia par Eurazeo ; les OPAs de SuperSonic Imagine, Coheris, TxCell et Orolia ; et les introductions en bourse de Medincell et Pharnext.

Expérience

  • Fluxys participates in €116 million financing of John Cockerill HydrogenJones Day advised Fluxys as co-investor in connection with the €116 million financing of John Cockerill Hydrogen, a company specializing in green hydrogen solutions.
  • Consortium of investors leads Melvan's €25 million fundraisingJones Day advised a consortium of investors led by Bpifrance, IDIA Capital Investissement, a pool of other investors from the Crédit Agricole group, and OCCTE, in connection with the €25 million financing of Melvan, a French producer and developer of multi-technology renewable energies.
  • Serena Capital and Crane Venture Partners lead $9 million seed financing of pyannoteAIJones Day advised Serena Capital and Crane Venture Partners in connection with the $9 million seed financing of pyannoteAI, the first language-agnostic speaker intelligence platform for developers.
  • CVE Biogaz raises €70 millionJones Day advised CVE Biogaz, a major player in organic matter recovery and methanization in France, in raising €70 million from BNP Paribas Asset Management, accelerating its development and strengthening its position in the European methanization market.
  • Kyotherm raises €300 millionJones Day advised Kyotherm, a co-developer and financer of renewable heat and energy efficiency projects, in connection with its €300 million financing led by InfraVia Capital Partners and existing investor, Andera Partners.
  • Tikehau Capital co-leads €8.5 million fundraising for OSS VenturesJones Day advised Tikehau Capital in connection with the €8.5 million fundraising of OSS Ventures, a leading industrial start-up studio in France, for propelling the future of operations, also led by France 2030's French Tech Accélération 2 fund (Bpifrance) and Etablissements Peugeot.
  • Doctolib acquires Aaron.aiJones Day advised Doctolib, the leading healthtech company in Europe, in its acquisition of the Berlin company Aaron.ai, the current market leader in Germany for AI-based telephone assistance solutions for medical practices, relieving doctors and practice staff of answering telephone calls and offering patients telephone access to doctors' practices around the clock.
  • Cellectis and AstraZeneca enter into research collaboration and agree on equity investment of up to $220 million by AstraZenecaJones Day advised Cellectis in connection with the joint research collaboration agreement entered into with AstraZeneca and initial equity investment by AstraZeneca into Cellectis of $80 million.
  • Radial Equity acquires Moss Motors and Rimmer BrosJones Day advised Radial Equity Partners in the acquisition and financing of Moss Motors, a U.S.-headquartered aftermarket supplier of parts for British cars, and Rimmer Bros, a UK-based supplier of replacement parts for UK marque vehicles.
  • VIALINK sold to SignaturitJones Day advised VIALINK in the sale of the company to PSG-backed Signaturit.
  • Serena invests in KotzillaJones Day advised Serena Capital in the $2 million seed financing of Kotzilla, a French company engaged in the development and marketing of an application monitoring developer platform.
  • Caisse des Depots et Consignation invests in European submarine cable MedloopJones Day advised Caisse des Depots et Consignation ("CDC") with its investment in Fiberspirit, a SPV owning and operating the European submarine cable system managed by Medloop connecting France, Spain, and Italy.
  • NANO Corp raises €4.2 million in seed financingJones Day advised NANO Corp, a cybersecurity firm providing software-based network detection and response (NDR) solutions, in connection with its €4.2 million seed financing, led by G+D Ventures.
  • Contentsquare acquires HeapJones Day acted as French counsel to Contentsquare in the acquisition of Heap, a leading U.S. product analytics platform.
  • DJUST raises €12 million in Series A financingJones Day represented DJUST, a B2B eCommerce SaaS platform, in connection with its €12 million Series A growth funding led by New Enterprise Associates, Inc. (NEA), with additional participation from Elaia Partners.
  • Sofinnova and NVentures co-lead $55.4 million financing of Moon SurgicalJones Day advised Sofinnova Partners (through Sofinnova Capital Strategy) and NVentures (NVIDIA's venture capital arm) as lead investors in connection with the $55.4 million financing of Moon Surgical, a French-American pioneer in collaborative robotics.
  • CVE raises €100 million from ICG InfraJones Day advised CVE, a France-based independent producer of renewable energy across multiple countries and sources of power, in connection with its €100 million financing round led by Intermediate Capital Group plc, a global alternative asset manager, through its infrastructure investment arm (ICG Infra).
  • Portage and Orange Ventures lead €37 million Series C financing of MooncardJones Day advised Portage and Orange Ventures as lead investors in connection with the €37 million Series C financing of Mooncard, the French leader in the automation of corporate spend, in which historical investors Aglaé Ventures, BlackFin Capital Partners, Partech Partners and RAISE Ventures also participated.
  • Welcome to the Jungle raises €50 million in Series C financingJones Day represented Welcome to the Jungle, a company that develops and operates a recruitment and employer branding solution, in connection with its €50 million Series C financing led by Cipio Partners and Blisce alongside new investors, Kostogri, Groupe ADP, and Raise Sherpas, and existing investors, Revaia, XAnge, and Bpifrance (Digital Venture).
  • Fintecture raises €26 million in Series A financingJones Day advised Fintecture, a pioneering next-gen B2B payment platform, in connection with its €26 million Series A financing led by new investors Eurazeo, RTP Global, HEC Ventures, Allianz Trade with existing investors Target Global, Samaipata and Business Angels also participating.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.